Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04747119
Other study ID # P.T. REC/012/002864
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2020
Est. completion date January 30, 2021

Study information

Verified date February 2021
Source October 6 University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To investigate the effect of muscle energy technique on Femoral meralgia paraesthesia in a postpartum female. BACKGROUND: meralgia paraesthesia is one of the serious disorders in the postpartum female which results in pain and less physical activities. ………HYPOTHESES: This study hypothesized that: muscle energy technique will have a significant effect on Femoral meralgia paraesthesia in postpartum female


Description:

Thirty meralgia paraesthesia postpartum females will participate in this study. The patients will randomly be divided into two equal groups; the control group received the conventional selected exercise program and the study group received the same exercise training program in addition to muscle energy technique, three times per week for four weeks. The evaluation methods by Femoral nerve conduction velocity will be measured via the Neuropack S1 MEB9004 EMG device before the exercise program and after finishing the exercise program, and also the Pelvic compression test and Pain numeric rating scale


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date January 30, 2021
Est. primary completion date December 30, 2020
Accepts healthy volunteers No
Gender Female
Age group 25 Years to 40 Years
Eligibility Inclusion Criteria: - Thirty meralgia paraesthesia postpartum female Patients - with positive Pelvic compression test - age ranging from 25:40 years - post vaginal delivery or post-operative (postpartum) persistent dysthesia in anterolateral thigh (one side or both) - body mass index (20:29.9) Kg/m2 Exclusion Criteria: - difficulty to communicate or to understand program instructions - other conditions that caused pain (for example fibromyalgia and arthritis) - any psychiatric or cognitive symptoms any other musculoskeletal disorders or neurologic diseases of the lower extremities and spine

Study Design


Related Conditions & MeSH terms


Intervention

Other:
muscle energy technique
the patient was supine and the therapist fix the lower limb of the affected side then ask the patient to perform isometric contraction for abductors maintained for 3-5 seconds, then the patient was instructed to stop, exhale and relax then the therapist perform further adducted the patient's knee of the affected side as a stretching exercise for Three to five repetitions of these directions were performed.
conventional selected physical therapy
life style modification Transcutaneous electrical nerve stimulation (TENS) Flexibility stretching exercises to the hip flexors

Locations

Country Name City State
Egypt Lama S Mahmoud Al Jizah Select State

Sponsors (1)

Lead Sponsor Collaborator
October 6 University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Femoral nerve conduction latency Femoral nerve conduction latency measured via the Neuropack S1 MEB9004 EMG device 4 weeks
Secondary Pelvic compression test the therapist applied a downward compression force to the pelvis and maintained a pressure for 45 seconds. If the patients reported an alleviation of symptoms the test is considered positive four weeks
Secondary Numeric Pain Rating Scale (NPRS) it includes 11-point numeric scale ranges from no pain with score of "0" to worst pain imaginable with score of "10" four weeks
See also
  Status Clinical Trial Phase
Completed NCT06187883 - Pulsed Radiofrequency of Lateral Femoral Cutaneous Nerve
Completed NCT02577510 - Comparing Ways to Freeze the Nerve That Provides Thigh Sensation Phase 3
Withdrawn NCT04046406 - Pelvic Pain Treated With MR-guided Cryoanalgesia N/A
Recruiting NCT05893732 - HILT for Meralgia Paresthetica: A Randomized Controlled Trial N/A
Completed NCT06251882 - Efficacy of Ultrasound-guided Injection of 5% Dextrose for Meralgia Paresthesia N/A
Completed NCT04004052 - Conservative Treatment and Ultrasound Guided Injection for Treatment Meralgia Paresthetica N/A
Completed NCT04499911 - Efficacy of Neural Prolotherapy in Treatment of Meralgia Paresthetica N/A